AstraZeneca: Revenue and EPS summary 9M 2025 % Change Q3 2025 % Change $m Actual CER1 $m Actual CER - Product Sales 41,035 9 9 14,365 11 9 - Alliance ...
AZ has already made it clear its focus is on investing in the US market – which accounts for 30% of its sales – and started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback